|
| Exchange Disseminated Time | | IOL Chemicals & Pharmaceuticals Ltd has informed BSE that Independent Directors in their meeting held on March 30, 2015, inter alia, evaluated the performance of non-independent directors and the Board as a whole; evaluated the performance of the Chairman of the Company and assessed the quality, quantity and timeliness of flow of information between the Company management and the Board in line with the requirement of Clause 49 of the Listing Agreement read with applicable provisions of Schedule IV of the Companies Act, 2013. |
|
|